menu
    • menu

    Company profile for Timber Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Timber Pharmaceuticals was founded in 2019 to develop treatments for unmet needs in medical dermatology. We have a particular focus on rare diseases or conditions of the skin for which there are no current treatments. Rare skin diseases are among the most neglected therapeutic areas in the pharmaceutical industry. Over 450 different rare skin diseases have been identified, and yet there have been only 17 FDA Approvals for eigh...
    Timber Pharmaceuticals was founded in 2019 to develop treatments for unmet needs in medical dermatology. We have a particular focus on rare diseases or conditions of the skin for which there are no current treatments. Rare skin diseases are among the most neglected therapeutic areas in the pharmaceutical industry. Over 450 different rare skin diseases have been identified, and yet there have been only 17 FDA Approvals for eight different rare dermatological conditions since the Orphan Drug Act was passed in 1983.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Timber PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Tice Blvd, Suite A26 Woodcliff Lake, NJ 07677
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.timberpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/timber-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Timber Pharma Updates TMB-001 Development For Congenital Ichthyosis
    Timber Pharma Updates TMB-001 Development For Congenital Ichthyosis

    21 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821853809/en

    BUSINESSWIRE
    21 Aug 2024
    Share Share
    Timber Pharmaceuticals Presents Late-Breaking Preliminary Results of TMB-001
    Timber Pharmaceuticals Presents Late-Breaking Preliminary Results of TMB-001

    10 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240310740543/en

    BUSINESSWIRE
    10 Mar 2024
    Share Share
    NYSE American to Suspend Trading Immediately in Timber Pharma
    NYSE American to Suspend Trading Immediately in Timber Pharma

    29 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231129559960/en

    BUSINESSWIRE
    29 Nov 2023
    Share Share
    Timber Announces Commencement of NYSE American Delisting Proceedings
    Timber Announces Commencement of NYSE American Delisting Proceedings

    29 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/29/2788134/0/en/Timber-Pharmaceuticals-Announces-Commencement-of-NYSE-American-Delisting-Proceedings-Common-Stock-Expected-to-Begin-Trading-on-the-OTC-Market.html

    GLOBENEWSWIRE
    29 Nov 2023
    Share Share
    Timber Receives Court Approval of All “First Day” Motions to Support Operations
    Timber Receives Court Approval of All “First Day” Motions to Support Operations

    28 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/28/2787404/0/en/Timber-Pharmaceuticals-Receives-Court-Approval-of-All-First-Day-Motions-to-Support-Business-Operations-Discloses-Communication-From-NYSE-American.html

    GLOBENEWSWIRE
    28 Nov 2023
    Share Share
    Timber Announces NYSE Acceptance of Plan to Regain Listing Compliance
    Timber Announces NYSE Acceptance of Plan to Regain Listing Compliance

    18 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/18/2745173/0/en/Timber-Pharmaceuticals-Announces-NYSE-Acceptance-of-Plan-to-Regain-Listing-Compliance.html

    GLOBENEWSWIRE
    18 Sep 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search